Concepedia

Chiara Ambrogio

CA

54

Publications

3.8K

Citations

38

H-Index

2005

Active since

Affiliations

University of Turin(Current)

Dana-Farber Cancer Institute

Harvard University

Boston Children's Hospital

Spanish National Cancer Research Centre

Chiara Ambrogio is an author at University of Turin specializing in medicine, cell biology, and tumor biology.

Top concepts

MedicineCell BiologyCell SignalingTumor BiologyImmunologyLung CancerRadiation OncologySignal TransductionOncologyTumor Microenvironment

Publications per year

2005–2025

54

Publications

54

KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS

Chiara Ambrogio, Jens Köhler, Zhi-Wei Zhou et al. · Cell · 2018 · 281 citations · Full text

Oncogenic Activity, Receptor Tyrosine Kinase, Mutant Kras +3

Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy

Matthew Holderfield, Bianca J. Lee, Jingjing Jiang et al. · Nature · 2024 · 268 citations · Full text

Simple and Rapid In Vivo Generation of Chromosomal Rearrangements using CRISPR/Cas9 Technology

Rafael B. Blasco, Elif Karaca, Chiara Ambrogio et al. · Cell Reports · 2014 · 210 citations · Full text

Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma

Chiara Ambrogio, Gonzalo Goméz-López, Mattia Falcone et al. · Nature Medicine · 2016 · 179 citations · Full text

Tumor Biology, Medicine, Therapeutic Strategy +11

A Braf kinase-inactive mutant induces lung adenocarcinoma

Patricia Nieto, Chiara Ambrogio, Laura Esteban-Burgos et al. · Nature · 2017 · 149 citations · Full text

Tumor Biology, Receptor Tyrosine Kinase, Bronchial Neoplasm +5

Rows per page

1–5 of 54